$ALXN Recent Headlines Are consumers getting gouged on

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2014 at 11:52 AM

$ALXN Recent Headlines

Are consumers getting gouged on health care? 9:36 a.m. Nov. 22, 2014 - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang

United Therapeutics: Will It Pass Peers In 2015? 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
IBD 50: Growth Stocks Fight The Fight In Weak Tape 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals 4:21 p.m. Dec. 11, 2014 - TheStreet.com
ChemoCentryx: Can It Break Into The Soliris Market? 3:08 p.m. Dec. 11, 2014 - Seeking Alpha
Are Investors Signaling Optimism in Biotechs Through Short Interest? 9:24 a.m. Dec. 10, 2014 - 247WallSt.com
Insider Trading Alert - PNW, BCEI And ALXN Traded By Insiders 12:28 p.m. Dec. 9, 2014 - TheStreet.com
Two Gauges That Point To Fund Buying In A Stock 5:18 p.m. Dec. 8, 2014 - Investors Business Daily
Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc. 9:41 a.m. Dec. 8, 2014 - GuruFocus.com
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY 9:37 a.m. Dec. 8, 2014 - GuruFocus.com
Inside The IBD 50: Challenging Time For Growth Stocks 5:54 p.m. Dec. 5, 2014 - Investors Business Daily
3 Growth Stocks In Buy Range After Recent Breakouts 5:41 p.m. Dec. 3, 2014 - Investors Business Daily
Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog 10:51 a.m. Dec. 3, 2014 - Zacks.com
Stock Market News for December 03, 2014 - Market News 10:10 a.m. Dec. 3, 2014 - Zacks.com
Today Alexion Pharmaceuticals (ALXN) Hits New Lifetime High 9:46 a.m. Dec. 3, 2014 - TheStreet.com
Meet 5 Big Caps Whose Earnings Are Expected To Surge 7:02 a.m. Dec. 3, 2014 - Investors Business Daily
Apple, Facebook: Jason Weiner Of Fidelity's View 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Valeant's Onexton Gel Gets FDA Approval for Acne - Analyst Blog 6:30 p.m. Dec. 1, 2014 - Zacks.com
Some Big Cap 20 Names Holding Up In Monday's Sell-Off 5:58 p.m. Dec. 1, 2014 - Investors Business Daily
Newly Profitable Medivation Riding High On Drug Sales 4:20 p.m. Nov. 28, 2014 - Investors Business Daily

X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders 8:57 a.m. Dec. 11, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 4:15 p.m. Dec. 10, 2014 - BusinessWire - BZX
New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment 9:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England 4:46 a.m. Nov. 27, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica 6:30 a.m. Nov. 25, 2014 - BusinessWire - BZX
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
WuXi PharmaTech Announces Appointment of William R. Keller to Board 8:00 a.m. Sept. 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Breaking Down Oklahoma's Car Insurance Costs

Understanding Car Insurance Dynamics in Oklahoma In the labyrinth of car insurance premiums, drivers in Oklahoma are left navigating a multitude of factors. A recent article from HelloNation, featuring insurance agent Bobby Williamson, dives into these elements with a candor that cuts through the fluff. Understanding what drives those numbers up or down isn't just for the...

AI Deepfakes Met Their Match: IC-Corp's New Patent

The Deepfake Fraud Reality Slap You know, in a world where you can't trust your own eyes on a video call, trust gets a bit sketchy, right? Imagine this scenario—an unsuspecting finance employee, surrounded by familiar faces and voices, only to wind up sending $25.6 million to fraudsters who weren't even real. A chilling real-world example from January 2024, courtesy of...

GM Ditches NYSE for Nasdaq: What to Expect?

The Big Migration: GM Moves to Nasdaq You know when an old dog changes its turf, it's looking for some new tricks. General Motors (NYSE: GM) has decided to pack its bags and leave the New York Stock Exchange (NYSE) for the Nasdaq Global Select Market. They’re sticking with the same ticker, "GM," but you can expect that big switcheroo come November 17, 2026. I can't be...

Co-Diagnostics Nearing India TB Test Launch By 2026

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

HIMS Lawsuit: Investors Under the Gun Before Deadline

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Switchgear Monitoring Market Surges to $3.80 Billion

Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....

Webull Faces Investor Lawsuit: Compliance in Question

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

EDGE Sound Research Boosted by $2M from Stormbreaker

EDGE Sound Research: Shaping Future with Sound Folks are starting to whisper more about EDGE Sound Research these days, and for good reason. This little outfit based out of Riverside, California just took in another $2 million from Stormbreaker Ventures, lifting its total funding to $9 million. But what are they doing with all that cash? They're building the perception...

XCMG Lends Heavy Equipment to Nairobi Rescue Effort

When Buildings Fall and Heavy Equipment Matters Buildings aren't supposed to just topple over. It's not some new trend I missed, but when it does happen, you've got a crisis – and that's exactly what unfolded in Nairobi on October 23 when an 18-story tower gave out, crashing down into chaos in the Eastleigh neighborhood. From Ground Zero to Immediate Response Imagine...

Exploring Family, Faith, and Forgiveness in New Book

Diving into the Depths of Faith and Forgiveness T.L. Dennis ain't just spinning a yarn about his childhood in "A Conversation with a Dead Father". This is a deep dive into the gritty realities of his relationship with his old man, seasoned with the salt of personal struggles and spiritual redemption. The pages of this book open at the one place none of us look for good...